Sheets Smith Wealth Management Edwards Lifesciences Corp Transaction History

Sheets Smith Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 28, 2020	SELL	$52.41 - $81.0 $266,557 - $411,966	-5,086 Closed	0 $0
Q4 2019 Jan 24, 2020	SELL	$71.7 - $82.09 $7,671 - $8,783	-107 Reduced 2.06%	5,086 $1.18 Million
Q3 2019 Oct 28, 2019	BUY	$61.55 - $75.43 $11,140 - $13,652	181 Added 3.61%	5,193 $1.14 Million
Q2 2019 Jul 12, 2019	SELL	$55.74 - $64.41 $4,069 - $4,701	-73 Reduced 1.44%	5,012 $926,000
Q1 2019 May 13, 2019	BUY	$47.89 - $64.05 $670 - $896	14 Added 0.28%	5,085 $973,000
Q3 2018 Oct 15, 2018	BUY	$45.7 - $58.03 $231,744 - $294,270	5,071 New	5,071 $883,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Sheets Smith Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Sheets Smith Wealth Management with notifications on news.